Zobrazeno 1 - 10
of 95
pro vyhledávání: '"Allan Moore"'
Autor:
Allan Moore, Paul Carr
The Bloomsbury Handbook of Rock Music Research is the first comprehensive academic survey of the field of rock music as it stands today. More than 50 years into its life and we still ask - what is rock music, why is it studied, and how does it work,
Publikováno v:
Lung Cancer. 173:71-74
BRAF inhibitors have been shown in clinical trials to improve patient outcomes in non-small cell lung cancer (NSCLC) patients harbouring selected BRAF driver mutations with a limited side effect profile, and therefore show potential as therapeutics i
Autor:
David Allan Moore, Marina Kushnir, Gabriel Mak, Helen Winter, Teresa Curiel, Mark Voskoboynik, Michele Moschetta, Nataliya Rozumna-Martynyuk, Kevin Balbi, Philip Bennett, Martin Forster, Anjana Kulkarni, Debra Haynes, Charles Swanton, Hendrik-Tobias Arkenau
Publikováno v:
ESMO Open, Vol 4, Iss 2 (2019)
Background The increasing frequency and complexity of cancer genomic profiling represents a challenge for the oncology community. Results from next-generation sequencing–based clinical tests require expert review to determine their clinical relevan
Externí odkaz:
https://doaj.org/article/8a8e79456bcd4fc59651004ea5d3201e
Publikováno v:
Mass Graves, Truth and Justice ISBN: 9781800882386
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e7e5700363886f9a3d41235ceecbd33f
https://doi.org/10.4337/9781800882386.00011
https://doi.org/10.4337/9781800882386.00011
Autor:
Phillipe Taniere, Andrew G Nicholson, John R Gosney, Maria Angeles Montero Fernandez, Danielle Bury, David Allan Moore, Eldo Verghese, Irshad Soomro, Leena Joseph, Nidhi Bhatt, Patrizia Viola, Rozinder Bains, Adrienne G Lanctot, Jacqueline Ryan
Publikováno v:
Journal of Clinical Pathology. :jcp-2023
AimsCancer diagnostics have been evolving rapidly. In England, the new National Health Service Genomic Medicine Service (GMS) provides centralised access to genomic testing via seven regional Genomic Laboratory Hubs. The PATHways survey aimed to capt
The lung is a common site of primary cancer and there is a wide range of tumor types which arise in the lung. These tumors vary widely in their morphology, molecular characteristics, outcome and response to therapy. The accurate classification of lun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bcc62c546e6ce067d0f0f4d7693125be
https://doi.org/10.1016/b978-0-12-801238-3.11700-3
https://doi.org/10.1016/b978-0-12-801238-3.11700-3
Autor:
Saba Ferdous, Charles Swanton, Francesca Chemi, Chang Sik Kim, Selvaraju Veeriah, Ged Brady, Sakshi Gulati, Deborah J. Burt, Mariam Jamal-Hanjani, Fiona H Blackhall, Daniel Slane-Tan, Nicholas McGranahan, Jackie Pierce, Marek Dynowski, Crispin J. Miller, Barbara Mesquita, Dominic G. Rothwell, Cong Zhou, David Allan Moore, Simon P. Pearce, Fabio Gomes, Philip A.J. Crosbie, Jonathan Tugwood, Nicolai Juul Birkbak, R. Shah, Gareth A. Wilson, Christopher Abbosh, Sophia Ward, Maise Al Bakir, Allan Hackshaw, Crispin T. Hiley, Caroline Dive, Dhruva Biswas, Yvonne Summers
Publikováno v:
Chemi, F, Rothwell, D G, McGranahan, N, Gulati, S, Abbosh, C, Pearce, S P, Zhou, C, Wilson, G A, Jamal-Hanjani, M, Birkbak, N, Pierce, J, Kim, C S, Ferdous, S, Burt, D J, Slane-Tan, D, Gomes, F, Moore, D, Shah, R, Al Bakir, M, Hiley, C, Veeriah, S, Summers, Y, Crosbie, P, Ward, S, Mesquita, B, Dynowski, M, Biswas, D, Tugwood, J, Blackhall, F, Miller, C, Hackshaw, A, Brady, G, Swanton, C, Dive, C & TRACERx Consortium 2019, ' Pulmonary venous circulating tumor cell dissemination before tumor resection and disease relapse ', Nature Medicine, vol. 25, no. 10, pp. 1534-1539 . https://doi.org/10.1038/s41591-019-0593-1
TRACERx Consortium 2019, ' Pulmonary venous circulating tumor cell dissemination before tumor resection and disease relapse ', Nature Medicine, vol. 25, no. 10, pp. 1534-1539 . https://doi.org/10.1038/s41591-019-0593-1
TRACERx Consortium 2019, ' Pulmonary venous circulating tumor cell dissemination before tumor resection and disease relapse ', Nature Medicine, vol. 25, no. 10, pp. 1534-1539 . https://doi.org/10.1038/s41591-019-0593-1
Approximately 50% of patients with early-stage non-small-cell lung cancer (NSCLC) who undergo surgery with curative intent will relapse within 5 years1,2. Detection of circulating tumor cells (CTCs) at the time of surgery may represent a tool to iden
Autor:
Emery, Allan Moore
Publikováno v:
American Literature, 1983 Oct 01. 55(3), 316-331.
Externí odkaz:
https://www.jstor.org/stable/2925677
Autor:
Emery, Allan Moore
Publikováno v:
Nineteenth-Century Fiction, 1984 Jun 01. 39(1), 48-68.
Externí odkaz:
https://www.jstor.org/stable/3044821
Autor:
Emery, Allan Moore
Publikováno v:
Nineteenth-Century Fiction, 1976 Sep 01. 31(2), 170-187.
Externí odkaz:
https://www.jstor.org/stable/2933500